Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial

We report final event-driven analysis data on the immunogenicity and efficacy of the human papillomavirus 16 and 18 ((HPV-16/18) AS04-adjuvanted vaccine in young women aged 15 to 25 years from the PApilloma TRIal against Cancer In young Adults (PATRICIA). The total vaccinated cohort (TVC) included a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Vaccine Immunol
Päätekijät: Apter, Dan, Wheeler, Cosette M., Paavonen, Jorma, Castellsagué, Xavier, Garland, Suzanne M., Skinner, S. Rachel, Naud, Paulo, Salmerón, Jorge, Chow, Song-Nan, Kitchener, Henry C., Teixeira, Julio C., Jaisamrarn, Unnop, Limson, Genara, Szarewski, Anne, Romanowski, Barbara, Aoki, Fred Y., Schwarz, Tino F., Poppe, Willy A. J., Bosch, F. Xavier, Mindel, Adrian, de Sutter, Philippe, Hardt, Karin, Zahaf, Toufik, Descamps, Dominique, Struyf, Frank, Lehtinen, Matti, Dubin, Gary
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2015
Aiheet:
Vaccines
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4375348/
https://ncbi.nlm.nih.gov/pubmed/25651922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00591-14
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia